文献速递消化系统肿瘤

治愈性结直肠癌术后的患者主导随访:前瞻性多中心FUTURE-primary实施研究的主要结局分析

Patient-led follow-up after curative colorectal cancer surgery: The primary outcome analysis of the prospective, multicentre FUTURE-primary implementation study.
PubMed 文献 · Eur J Cancer · 2025-07-08

FUTURE-primary是一项前瞻性多中心实施研究,纳入209例治愈性结直肠癌术后患者,允许其个性化随访频率、采血地点和沟通方式。1463个可选随访节点中488个(33%)未使用,超过预设25%阈值,达到主要终点;66%患者偏好居家采血,70%选择电话咨询而非面诊。患者主导随访可行且可接受。

要点

  • 可选随访节点未使用率为33%,超过预设25%阈值,主要终点达到。
  • 66%患者偏好居家采血,70%选择电话咨询而非面诊。
  • 患者主导随访在治愈性结直肠癌术后可行且可接受。

核心结论

  • 治愈性结直肠癌术后患者主导随访可行且可接受,该模式可能减少不必要的医院就诊、提高患者自主性并促进更可持续的癌症幸存者照护。

研究设计与样本

  • FUTURE-primary为前瞻性多中心实施研究,分析209例接受治愈性手术后符合标准随访条件的原发性结直肠癌患者数据。

主要发现

  • 1463个可选随访节点中488个(33%)未使用,超过预设25%阈值,达到主要终点。
  • 66%患者偏好居家采血。
  • 70%患者选择电话咨询而非面诊。

关键数值与推荐

  • 最短随访方案依照国家指南为5年内7次强制咨询。
  • 另设7个可选随访节点供患者按需追加随访。
  • 可选随访节点未使用率33%超过预设阈值25%,主要终点达到。

临床怎么用

  • 患者可个性化随访频率、采血地点(居家、当地机构或医院)和沟通方式(「静默」、电话或面诊)。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A structured follow-up regimen is standard for most cancer survivors. As this population grows, there is increasing interest in more sustainable and patient-centred follow-up strategies. Previous studies suggest that home-based follow-up after curative treatment is non-inferior to hospital-based care regarding survival and quality of life. The FUTURE-primary study aims to evaluate the feasibility of a patient-led, home-based follow-up model for colorectal cancer survivors. METHODS: The FUTURE-primary study is a prospective, multicentre implementation study. Patients who had undergone curative-intent surgery for primary colorectal cancer and were eligible for standard follow-up could personalise their care pathway. Options included the frequency of follow-up, location of blood sampling (home, local facility, or hospital), and communication method ('silent', telephone, or in-person). The minimal follow-up schedule consisted of seven mandatory consultations over five years, in accordance with national guidelines. In addition, seven optional follow-up moments were available, allowing patients additional follow-up where needed. FINDINGS: Data from 209 patients were analysed. Of 1463 optional follow-up moments, 488 (33 %) remained unused, surpassing the pre-defined threshold of 25 % and thereby meeting the primary endpoint. Home-based blood sampling was preferred by 66 % of patients, while 70 % chose telephone consultations over physical appointments. INTERPRETATION: Patient-led follow-up after curative colorectal cancer surgery is feasible and acceptable. The model may reduce unnecessary hospital visits, improve patient autonomy, and contribute to more sustainable cancer survivorship care. Its principles are potentially applicable to other tumour types and care pathways. FUNDING: This study was funded by the Dutch Cancer Society (KWF Kankerbestrijding), grant number 9030.

来源:Eur J Cancer,查看原文。版权归原作者所有。

引用

  1. van Driel MHE, Wullaert L, Voigt KR, et al. Patient-led follow-up after curative colorectal cancer surgery: The primary outcome analysis of the prospective, multicentre FUTURE-primary implementation study. Eur J Cancer. 2025. PMID: 40712408. doi:10.1016/j.ejca.2025.115599

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。